Sign in to view content

Potential Safety Concerns of Bevacizumab for Retinopathy of Prematurity

Robert L. Avery, MD

Video
Published 2016

Related

Randomized Trial of Initiating Therapy With Aflibercept, Laser, or Observation for Eyes With Good Vision and Center-Involved DME
Carl W. Baker, MD, FASRS
Annual Meeting Talks
2019
Prophylaxis Intravitreal Aflibercept Against Conversion to Neovascular AMD in High-Risk Eyes (PRO-CON): 24-Month Results
Jeffrey S. Heier, MD
Annual Meeting Talks
2019
Dry AMD Symposium 2
Annual Meeting Talks
2020

Category: Pediatric Retina

See more